US Patent Issued to STEMCELL TECHNOLOGIES CANADA on Sept. 8 for "Intracellular delivery of biomolecules to modify immune response" (North Carolina, Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,163, issued on Sept. 8, was assigned to STEMCELL TECHNOLOGIES CANADA INC. (Vancouver, Canada).

"Intracellular delivery of biomolecules to modify immune response" was invented by Scott Loughhead (Durham, N.C.), LeeAnn Talarico (Milton, Mass.), Alfonso Vicente-Suarez (Brookline, Mass.), Matt Booty (Watertown, Mass.), Howard Bernstein (Cambridge, Mass.), Katarina Blagovic (Cambridge, Mass.), Armon R. Sharei (Somerville, Mass.) and Kelan Hlavaty (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides T cells comprising an antigen and an adjuvant, methods of manufacturing such T cells, and methods of using such T c...